The implementation of the next Texas Medicaid Preferred Drug List (PDL) has been delayed until Thursday, Feb. 1, 2018, and will include only those changes approved at the Jul. 28, 2017, Drug Utilization Review (DUR) Board meetings. There will be a follow-up implementation at a later date to deploy those changes recommended at the Nov. 3, 2017, DUR board meeting.